BioGaia Reports 9% Sales Growth in 2016

a10c9b81-d886-4137-9cda-f4a798f3ec08articleimage.jpg

14 Feb 2017 --- Swedish probiotics manufacturer, BioGaia, has announced an annual sales growth of 9% in 2016 - a growth that the company is in part attributing to its continued success in the Asian market.

The company’s net sales amounted to SEK 534.7 million ($60 million) in 2016.

“Looking back at 2016, we can only feel satisfied,” says Axel Sjöblad, Managing Director of BioGaia AB.

“With sales growth of 9% excluding foreign exchange effects, we were able to pass the half billion mark and achieve annual sales of SEK 534.7 million ($60 million).”

“This enabled us to increase our market shares despite the fact that the sales to Brazil, one of our most important markets, were low as a result of the inventory build-up during 2015.”

“The operating profit, excluding the distributed former subsidiary IBT, reached SEK 199.4 million ($22.4 million), an increase of 14% excluding foreign exchange effects, which leads to an operating margin of 37%.”

“Our strong financial development, while we were building a platform for future growth and signing new distribution agreements in Japan and Thailand, demonstrates the strength of our business model, our employees and our products, and gives us reason to look to the future with continued confidence.”

Towards the end of Q4, BioGaia signed major agreements for the sale of BioGaia’s probiotic products in Japan, and the company also made a further investment in MetaboGen, a company researching the microbiome to understand health and disease, and creating opportunities to develop novel therapeutics and next generation probiotics.

And it looks like the year ahead is set to follow in 2016’s footsteps. So far in 2017, an agreement has been made for the sale of BioGaia’s products in Thailand, with the products being co-branded under BioGaia and Abbott brand.

“We have a strong focus on growing our Asian business and I am very pleased that BioGaia’s products will be available in another important country in the region,” says Axel Sjöblad.

“Based on the positive experience we already have in collaborating with Abbott in Latin America, I look forward to a successful launch of our products with Abbott in Thailand as well.”

Related Articles

Nutrition & Health News

Energetic growth: Energy boosters add pep to the nutritional space’s step

11 Dec 2017 --- Busy schedules can cause consumers to go through an “energy crisis” – prompting their desire to reach for products that might offer some support to their energy levels. Energy boosters are certainly showing signs of growth in all regions tracked by Innova Market Insights. A CAGR in supplement launches of +208.8 percent in South America from 2012 to 2016 is particularly noteworthy, while Europe is top of the pile worldwide with 28.8 percent of its supplement launches having an energy claim in 2016 and its CAGR amounting to a strong +86.7 percent.

Business News

Nutrition 21 launches US media campaign to support Velositol ingredient

11 Dec 2017 --- Nutrition 21, LLC has partnered with NYC-based media relations firm Pitch Publicity and clinical pharmacist James B. LaValle in a national media tour dedicated to educating consumers about the benefits of its proprietary ingredient, Velositol.

Food Ingredients News

Pea stars for Roquette amid alternative protein boom

11 Dec 2017 --- Roquette’s range of pea proteins took a starring role at FiE 2017, and would seem to have a bright future in products promoted by the company. According to the company’s representatives, a key highlight of the company’s newest range of products is around plant-based proteins – many of which are based on pea proteins.

Nutrition & Health News

Soy, cruciferous vegetables linked to fewer breast cancer treatment side effects

11 Dec 2017 --- Consuming soy foods and cruciferous vegetables – such as cabbages, kale, collard greens, bok choy, Brussels sprouts and broccoli – may be associated with a reduction in common side effects of breast cancer treatment in breast cancer survivors, according to a team of scientists led by Georgetown Lombardi Comprehensive Cancer Center. Understanding the role of life style factors with regard to the side effects is important because diet can serve as a modifiable target for possibly reducing symptoms among breast cancer survivors.

Business News

Lakeview Equity invests in nutritional solutions provider NutriScience Innovations

11 Dec 2017 --- Lakeview Equity Partners, LLC, a US$40 million Milwaukee, US-based private equity fund, has invested in NutriScience Innovations, LLC, based in Trumbull, Connecticut, US. NutriScience is a cGMP-certified global supplier of nutritional and functional ingredients to companies that manufacture nutraceutical, pharmaceutical, food and beverage, and dietary products.

More Articles
URL : http://www.nutritioninsight.com:80/news/BioGaia-Reports-9-Sales-Growth-in-2016.html?tracking=Nutrition%20and%20Health%20News